跳至主要内容
临床试验/NCT03299517
NCT03299517Unknown4 期

PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN PATIENTS WITH STABLE VENTRICULAR TACHYCARDIA IN THE EMERGENCY ROOM

University of Sao Paulo General Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年8月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
试验地点
1
主要终点
HR increase

研究概览

简要总结

Introduction: Recent studies have suggested that other medications may be superior to amiodarone in controlling ventricular arrhythmias. However, a prospective and randomized comparison with lidocaine has not yet been described.

Objective: This study aims to evaluate the effectiveness and safety of the use of amiodarone versus lidocaine in patients with stable ventricular tachycardias.

Methodology: For this, a unicentric, randomized and prospective study will be carried out, in which the two drugs will be administered in a comparative manner. Hospital data (test results, medical outcomes, arrhythmia reversal, complications) of patients will be analyzed for safety and effectiveness.

Expected results: The use of lidocaine is not inferior to amiodarone in the tolerability and reversion of stable ventricular tachycardias.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult men and women> 18 years old
  • Presence of sustained ventricular tachycardia with HR> 120 bpm
  • Systolic blood pressure> 90 mmHg
  • No signs of poor peripheral perfusion
  • Absence of dyspnea
  • Absence of severe angina
  • Signed consent form

排除标准

  • Pregnancy
  • Hemodynamic instability
  • Body mass index greater than 40 kg / m2
  • Use of intravenous amiodarone or lidocaine in the last 24 hours
  • Acute coronary syndrome
  • Presence of tachycardia with irregular or supraventricular RR
  • Contraindications to study drugs

研究组 & 干预措施

lidocaine

Experimental

Initial dose: antiarrythmic drugs Lidocaine (1.5 mg / kg EV in 30 minutes).

Adittional dose: Lidocaine (0.75 mg / kg EV in 30 minutes).

干预措施: Antiarrythmic Drugs (Drug)

amiodarone

Experimental

Initial dose: antiarrythmic drugs Amiodarone (5 mg / kg EV in 30 minutes)

Adittional dose: Amiodarone (3 mg / kg EV in 30 minutes)

干预措施: Antiarrhythmic drugs (Drug)

结局指标

主要结局

HR increase

时间窗: 1 hour

HR increase\> 20 bpm.

Signs of peripheral hypoperfusion and shock

时间窗: 1 hour

hypoperfusion and shock

Signs of pulmonary congestion

时间窗: 1 hour

dyspnea, orthopnea, onset of pulmonary rales or drop in oximetry.

Severe hypotension

时间窗: 1 hour

systolic blood pressure \<70 mmHg if the previous one is \<100 mmHg or systolic blood pressure \<80 mmHg if the previous one is \> 100 mmHg).

Lowering the level of consciousness.

时间窗: 1 hour

glasgow \< 15

The appearance of polymorphic TV.

时间窗: 1 hour

polymorphic TV.

次要结局

  • effectiveness of reversal(1 hour)
  • time required for reversal(1 hour)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验